13F Holdings
中文EN

SHC Sotera Health Co

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1822479 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.9%
TTM net income YoY213.0%
TTM EPS YoY200.0%
Revenue 3-yr CAGR7.5%
Net income 3-yr CAGR—

Margins

Gross margin54.6%
Operating margin—
Net margin14.1%
FCF margin11.0%
EBITDA margin—

Returns

ROE27.0%
ROA5.3%
ROIC (approx.)—
Asset turnover0.37x

Leverage & solvency

Liabilities / assets78.4%
Debt / equity2.91x
Current ratio3.13x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.91x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue16.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.16B$1.10B$1.05B$1.00B$931.48M
Cost of revenue$518.08M$498.15M$472.13M$446.68M$412.81M
Gross profit$645.53M$602.29M$577.16M$557.00M$518.67M
SG&A expense$252.76M$242.63M$236.67M$245.71M$198.16M
Operating income—$297.63M$276.69M$248.35M$256.73M
Pretax income$147.51M$113.87M$106.03M-$243.11M$175.72M
Income tax$69.56M$69.48M$54.65M-$9.54M$58.59M
Net income$77.95M$44.40M$51.38M-$233.57M$116.88M
EBITDA—$381.93M$353.29M$312.65M$320.93M
EPS (basic)0.270.160.18-0.830.41
EPS (diluted)0.270.160.18-0.830.41
Weighted avg. shares (diluted)286.42M284.91M283.22M280.10M279.38M
Balance sheet
Cash & equivalents$344.62M$278.87M$301.65M$396.29M$106.92M
Receivables$139.33M$140.33M$147.70M$118.48M$108.18M
Inventory$54.38M$49.16M$48.32M$37.15M$54.29M
Current assets$613.41M$526.04M$557.24M$645.01M$345.96M
PP&E, net$1.13B$1.04B$946.91M$774.53M$650.80M
Goodwill$1.10B$1.08B$1.11B$1.10B$1.12B
Intangibles$288.23M$317.65M$416.32M$491.26M$598.84M
Total assets$3.26B$3.07B$3.13B$3.12B$2.79B
Current liabilities$249.58M$191.00M$230.65M$791.57M$161.16M
Short-term debt$13.97M$14.80M$4.80M$197.12M$0
Long-term debt$2.13B$2.21B$2.22B$1.75B$1.74B
Total debt$2.14B$2.22B$2.23B$1.94B$1.74B
Total liabilities$2.66B$2.67B$2.69B$2.77B$2.20B
Shareholders' equity$606.03M$404.91M$443.73M$350.24M$586.10M
Net debt$1.80B$1.94B$1.93B$1.55B$1.64B
Cash flow statement
Operating cash flow$287.19M$224.16M-$147.73M$277.96M$281.55M
Capital expenditure$138.02M$179.07M$214.97M$182.38M$102.16M
Free cash flow$149.18M$45.09M-$362.71M$95.58M$179.38M
Investing cash flow-$135.14M-$179.00M-$214.91M-$181.90M-$159.83M
Financing cash flow-$100.53M-$50.56M$265.96M$197.76M-$117.29M
Depreciation & amortization$94.90M$84.30M$76.60M$64.30M$64.20M
Stock-based compensation$30.88M$36.78M$32.24M$21.21M$13.87M
Dividends paid————$0
Share buybacks———$0$0

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.